EUVIMEDEUVIMED entdecken
Crossref

Metformin protects chondrocytes against IL-1β induced injury by regulation of the AMPK/NF-κ B signaling pathway

Mengqi Zhang, Yaping Liu, Zhikun Huan, Yan Wang, Jin Xu

Die Pharmazie · 01.12.2020 · 75 (12)

DOI: 10.31083/ph.2020.0762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Die Pharmazie, online erschienen am 01.12.2020. Verfasst von Mengqi Zhang und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a common joint disorder characterized by degeneration and inflammation of the articular cartilage. The etiology of OA is complex, and there is no effective drug for the treatment currently. Metformin, the first-line drug for type 2 diabetes mellitus, has been reported to play an essential role in a variety of diseases; however, whether it could be used in OA therapy remains unclear. In this study, we used interleukin-1β (IL-1β) to mimic the pathophysiology of OA to explore the function and the underlying mechanism of metformin on OA. In our study, cell viability was measured using cell counting kit-8 assay, expressions of crucial factors involved in the extracellular matrix (ECM) metabolic, proinflammatory response, cell apoptosis, and nuclear factor κ B(NF-κ B) pathway were analyzed using western blot analysis and immunofluorescence staining. We found that metformin increased the proliferation of the cells, alleviated IL-1β-induced ECM metabolic imbalance and proinflammatory cytokine production, and exerted anti-apoptosis activity in ATDC5 cells. Furthermore, the results showed that metformin blocked the NF-κ B pathway in IL-1β-induced ATDC5 cells via activation of AMP-activated protein kinase (AMPK). These results indicated that metformin protected chondrocytes against IL-1β-induced injury, possibly by regulation of the AMPK/NF-κ B signaling pathway. It may have the potential as a novel drug for OA treatment.

Zitieren

APA

Zhang, M., Liu, Y., Huan, Z., Wang, Y., & Xu, J. (2020). Metformin protects chondrocytes against IL-1β induced injury by regulation of the AMPK/NF-κ B signaling pathway. Die Pharmazie, 75(12). https://doi.org/10.31083/ph.2020.0762

Vancouver

Zhang M, Liu Y, Huan Z, Wang Y, Xu J. Metformin protects chondrocytes against IL-1β induced injury by regulation of the AMPK/NF-κ B signaling pathway. Die Pharmazie. 2020;75(12). doi:10.31083/ph.2020.0762

BibTeX
@article{Zhang2020,
  author = {Zhang, Mengqi and Liu, Yaping and Huan, Zhikun and Wang, Yan and Xu, Jin},
  title = {Metformin protects chondrocytes against IL-1β induced injury by regulation of the AMPK/NF-κ B signaling pathway},
  journal = {Die Pharmazie},
  year = {2020},
  volume = {75},
  number = {12},
  doi = {10.31083/ph.2020.0762}
}
Kostenlos starten →